| 1 |
戚庆炜，孙念怙. 产前唐氏综合征筛查概论[J]. 实用妇产科杂志, 2008, 24(1): 4-7.
|
| 2 |
Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy[J]. BMJ, 1992, 304(6831): 867-869.
|
| 3 |
Bindra R, Heath V, Nicolaides KH. Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks[J]. Clin Obstet Gynecol, 2002, 45(3): 661-670.
|
| 4 |
Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A[J]. Ultrasound Obstet Gynecol, 2008, 31(6): 618-624.
|
| 5 |
Sahota DS, Leung TY, Chan LW, et al. Comparison of first-trimester contingent screening strategies for Down syndrome[J]. Ultrasound Obstet Gynecol, 2010, 35(3): 286-291.
|
| 6 |
张淑贞，刘华俭，杨银广, 等. 早孕期一站式唐氏综合征筛查的应用价值研究[J]. 中国医药指南, 2010, 31(8): 7-9.
|
| 7 |
Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening[J]. N Engl J Med, 2014, 370(9): 799-808.
|
| 8 |
Liao C, Yin AH, Peng CF, et al. Noninvasive prenataldiagnosis of common aneuploidies by semiconductor sequencing[J]. Proc Natl Acad Sci U S A, 2014, 111(20): 7415-7420.
|
| 9 |
黄苑铭，马小燕，黄冬平, 等. 超声检测孕11～13+6周胎儿颅内透明层的研究[J/CD]. 中华医学超声杂志:电子版, 2011, 8(4): 772-777.
|
| 10 |
Mäkikallio K, Jouppila P, Räsänen J. Human fetal cardiac function during the first trimester of pregnancy[J]. Heart, 2005, 91(3): 334-338.
|
| 11 |
Rizzo G, Muscatello A, Angelini E, et al. Abnormal cardiac function in fetuses with increased nuchal translucency[J]. Ultrasound Obstet Gynecol, 2003, 21(6): 539-542.
|
| 12 |
莫祝宁，李小玲. 胎儿颈项透明层在产前诊断中的研究进展[J]. 实用医技杂志, 2006, 10(13) : 3341-3344．
|
| 13 |
李胜利. 胎儿畸形产前超声诊断学[M]. 北京: 人民军医出版社, 2004: 567-570．
|
| 14 |
Souka AP, Skentou H, Geerts L, et al. Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester[J]. Prenat Diagn, 2002, 22(2): 93-95.
|
| 15 |
Tercanli S, Miny P, Siebert MS, et al. Fanconi anemia associated with increased nuchal translucency detected by first-trimester ultrasound[J]. Ultrasound Obstet Gynecol, 2001, 17(2): 160-162.
|
| 16 |
Sohan K, Carroll S, Byrne D, et al. Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester[J]. Fetal Diagn Ther, 2000, 15(4): 234-236.
|
| 17 |
Whitlow BJ, Economides DL. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester[J]. Ultrasound Obstet Gynecol, 1998, 11(4): 258-261.
|
| 18 |
Chaoui R, Benoit B, Mitkowska-Wozniak H, et al. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan[J]. Ultrasound Obstet Gynecol, 2009, 34(3): 249-252.
|
| 19 |
周朝辉，付倩，罗国阳, 等. 早孕期超声筛查新进展[J/CD]. 中华医学超声杂志:电子版, 2013, 10(1): 8-18.
|
| 20 |
Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome[J]. N Engl J Med, 2005, 353(19): 2001-2011.
|
| 21 |
Sahota DS, Leung TY, Chan LW, et al. Comparison of first-trimester contingent screening strategies for Down syndrome[J]. Ultrasound Obstet Gynecol, 2010, 35(3): 286-291.
|
| 22 |
Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype[J]. Am J Obstet Gynecol, 2005, 192(4): 1005-1021.
|
| 23 |
Hyett J, Sonek J, Nicolaides K. Nuchal translucency and the risk of congenital heart disease. FASTER Consortium[J]. Obstet Gynecol, 2007, 109(6): 1455-1457.
|
| 24 |
Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study[J]. BMJ, 1999, 318(7176): 81-85.
|
| 25 |
Fong KW, Toi A, Okun N, et al. Retrospective review of diagnostic performance of intracranial translucency in detection of open spina bifida at the 11-13 week scan[J]. Ultrasound Obstet Gynecol, 2011, 38(6): 630-634.
|
| 26 |
Tsai MS, Huang YY, Hwa KY, et al. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening[J]. J Formos Med Assoc, 2001,100(5): 319-325.
|
| 27 |
Zoppi MA, Putzolu M, Ibba RM, et al. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype[J]. Fetal Diagn Ther, 2002, 17(1): 52-57.
|
| 28 |
Toyama JM, Brizot ML, Liao AW, et al. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome[J]. Ultrasound Obstet Gynecol, 2004, 23(4): 341-345.
|
| 29 |
唐英，杨太珠，罗红, 等. 早孕期超声探查胎儿静脉导管血流频谱筛查染色体异常的价值[J]. 声学技术, 2011, 4(30): 449-452.
|